Lensar vs RxSight
LNSR and RXST side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How LNSR and RXST compare
RxSight is the larger company, worth 3.6 times as much as Lensar ($221M against $61.4M).
Lensar grew revenue faster over the last twelve months (1.6% versus −13.2% for RxSight).
Lensar keeps more of each dollar of sales as profit, with a net margin of 56.1% compared with −36.8% at RxSight.
RxSight scores higher on the StockData Score (10 against 7 for Lensar), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | LNSR | RXST |
|---|---|---|
| Size and price | ||
| Market cap | $61.4M | $221M |
| Share price | $5.00 | $5.32 |
| Change, 1 year | −52.0% | −46.9% |
| Change, 5 years | −29.6% | −60.7% |
| Beta (5Y) | 0.59 | 1.11 |
| Employees | 150 | 461 |
| StockData Score | ||
| Total score | 7 | 10 (better) |
| Valuation score | 1 | 3 (better) |
| Growth score | 2 | 2 |
| Performance score | 2 (better) | 1 |
| Health score | 2 | 4 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.0× (better) | 1.7× |
| P/B | 5.6× | 0.8× (better) |
| FCF yield | – | −12.3% |
| Fair value | $5.93 | $20.64 |
| Margin of safety | 15.7% | 74.2% (better) |
| Growth | ||
| Revenue growth (TTM) | 1.6% (better) | −13.2% |
| Revenue growth, 5Y average | 17.2% | 55.7% (better) |
| Profitability | ||
| Gross margin | 52.0% | 77.5% (better) |
| Operating margin | −3.3% (better) | −43.2% |
| Net margin | 56.1% (better) | −36.8% |
| FCF margin | – | −21.3% |
| Return on equity | – | −17.3% |
| Return on invested capital | – | −82.9% |
| Financial health | ||
| Debt / equity | 0.17 (better) | 0.00 |
| Interest coverage | – | −3674.3× |
| Current ratio | 2.25 | 4.07 (better) |
| Altman Z-score | −0.86 | −0.56 (better) |
| Piotroski F-score | 3 | 3 |
| Dividends and buybacks | ||
| Buyback yield | – | −0.90% |
| Shareholder yield | 0.00% (better) | −0.90% |
| Ownership | ||
| Held by institutions | 36.0% | 99.6% |
| Held by insiders | – | 5.4% |
| Insider net buying, 12 months | – | −$118K |
| Short interest, % of float | – | 9.2% |
Go deeper
- LNSR stock overview
- LNSR income statement
- LNSR valuation and score
- RXST stock overview
- RXST income statement
- RXST valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.